Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Sangeeta Ray Banerjee"'
Autor:
Rajan Singh, Anand K. Thotakura, Suresh Alati, Alla Lisok, Zirui Jiang, Vanessa F. Merino, Il Minn, Santosh Yadav, Mark C. Markowski, Yasser Ged, Christian P. Pavlovich, Nirmish Singla, Lilja B. Solnes, Michael A. Gorin, Martin G. Pomper, Steven P. Rowe, Sangeeta Ray Banerjee
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRenal cell carcinoma (RCC) represents cancer originating from the renal epithelium and accounts for > 90% of cancers in the kidney. Prostate-specific membrane antigen (PSMA) is overexpressed in tumor-associated neovascular endothelial cel
Externí odkaz:
https://doaj.org/article/0b43bcfa255e43f883bee194298d2a44
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/3a59cca7053246dd8093beb714c1db17
Autor:
Srikanth Boinapally, Suresh Alati, Zirui Jiang, Yu Yan, Alla Lisok, Rajan Singh, Gabriela Lofland, Il Minn, Robert F. Hobbs, Martin G. Pomper, Sangeeta Ray Banerjee
Publikováno v:
Molecules, Vol 28, Iss 16, p 6158 (2023)
Prostate-specific membrane antigen (PSMA)-based low-molecular-weight agents using beta(β)-particle-emitting radiopharmaceuticals is a new treatment paradigm for patients with metastatic castration-resistant prostate cancer. Although results have bee
Externí odkaz:
https://doaj.org/article/734b29638af746058bf55e89bc6c702b
Autor:
Ying Chen, Il Minn, Steven P. Rowe, Alla Lisok, Samit Chatterjee, Mary Brummet, Sangeeta Ray Banerjee, Ronnie C. Mease, Martin G. Pomper
Publikováno v:
Biomolecules, Vol 12, Iss 3, p 405 (2022)
We have synthesized a series of 10 new, PSMA-targeted, near-infrared imaging agents intended for use in vivo for fluorescence-guided surgery (FGS). Compounds were synthesized from the commercially available amine-reactive active NHS ester of DyLight8
Externí odkaz:
https://doaj.org/article/d1c1798ad8fc4d06822e7a76380de9fd
Autor:
Stavroula Sofou, Alfred Morgenstern, Frank Bruchertseifer, Martin G. Pomper, Sangeeta Ray Banerjee, Michelle Sempkowski, Amey Bandekar, Charles Zhu
This study aims to evaluate the effect on killing efficacy of the intracellular trafficking patterns of α-particle emitters by using different radionuclide carriers in the setting of targeted antivascular α-radiotherapy. Nanocarriers (lipid vesicle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f38227956279c2ebc6e780234dec488
https://doi.org/10.1158/1535-7163.c.6537633
https://doi.org/10.1158/1535-7163.c.6537633
Autor:
Stavroula Sofou, Alfred Morgenstern, Frank Bruchertseifer, Martin G. Pomper, Sangeeta Ray Banerjee, Michelle Sempkowski, Amey Bandekar, Charles Zhu
Viability (evaluated after one doubling time) of PSMA-positive HUVEC as a function of delivered radioactivity per cell.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ef343fa013d26495acd921df7ed0f5
https://doi.org/10.1158/1535-7163.22504143
https://doi.org/10.1158/1535-7163.22504143
Autor:
Zhihang Chen, Balaji Krishnamachary, Yelena Mironchik, Sangeeta Ray Banerjee, Martin G. Pomper, Zaver M. Bhujwalla
Publikováno v:
Nanoscale. 14(38)
Small interfering RNA (siRNA) is ideal for gene silencing through a sequence-specific RNA interference process. The redundancy and complexity of molecular pathways in cancer create a need for multiplexed targeting that can be achieved with multiplexe
Autor:
Hwanhee Nam, Il Minn, Mary Brummet, Martin G. Pomper, Kathleen L. Gabrielson, Srikanth Boinapally, Bei Cheng, Hye Hyun Ahn, Sangeeta Ray Banerjee
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specifi
Autor:
Anna Jablonska, Ala Lisok, Emad M. Boctor, Sangeeta Ray Banerjee, Srikanth Boinapally, Martin G. Pomper, Jeeun Kang, Yixuan Wu, Wojciech G. Lesniak
Publikováno v:
Nanoscale. 13:9217-9228
Prostate-specific membrane antigen (PSMA) is a promising diagnostic and therapeutic target for prostate cancer (PC). Poly(amidoamine) [PAMAM] dendrimers serve as versatile scaffolds for imaging agents and drug delivery that can be tailored to differe
Autor:
Ronnie C. Mease, Anders Josefsson, Cory Brayton, Mary Brummet, Ying Chen, Colette J. Shen, Ana P. Kiess, Sangeeta Ray Banerjee, Martin G. Pomper, Il Minn, Robert F. Hobbs
Publikováno v:
Theranostics
Auger radiopharmaceutical therapy is a promising strategy for micrometastatic disease given high linear energy transfer and short range in tissues, potentially limiting normal tissue toxicities. We previously demonstrated anti-tumor efficacy of a sma